Drug intelligence / Profile preview

Fecal microbiota transplantation (Soroka University Medical Center)

Development stage: Unknown
Lead developer: Soroka University Medical Center
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

This is an investigational fecal microbiota transplantation (FMT) being evaluated in a clinical trial at Soroka University Medical Center. [1-9, 3-8] The therapy consists of capsules containing fecal microbiota from donors who have completely responded to immunotherapy. [1-15] It is being studied for its safety and efficacy in enhancing the response to standard first-line immunotherapy, with or without chemotherapy, in patients with metastatic lung cancer. [1-9, 1-13, 3-8] The aim is to modulate the gut microbiome to improve the disease control rate. [1-14] The treatment is administered orally in capsules at the start of each (chemo-)immunotherapy cycle. [1-1, 1-2] The Phase 2 trial is registered as NCT05502913 and is funded by the Israel Cancer Association. [1-3, 1-20]

Other names: fecal microbiota transplantation-Soroka University Medical Center-metastatic lung cancerFMT

Beyond the preview

Go deeper on Fecal microbiota transplantation (Soroka University Medical Center).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fecal microbiota transplantation (Soroka University Medical Center).

Explore the full profile